Opioid tolerance may involve activation of the N-methyl-D-aspartate (NMDA) system. The possible involvement of the NMDA system suggests that one of the NMDA receptor antagonists, magnesium may be a useful adjunct to opioids for the treatment of postoperative pain following remifentanil infusion.
INTRODUCTION
Remifentanil a short-acting opioid with predictable and rapid recovery that is relatively independent of the dose. 1) A corollary of short action is that patients may experience considerable surgical pain in the immediate postoperative period. 2) Supplemental opioids are thus often given prophylactically to the patients who are likely to experience postoperative pain. 1) Despite this precaution, postoperative analgesic requirement in patients given intraoperative remifentanil is often surprisingly great. 3) This observation suggests that remifentanil may be associated with acute opioid tolerance.
Magnesium, first known for its efficacy in the treatment of arrhythmia and preeclmpsia, has recently been shown to have analgesic and anesthetic efficacy, prompting studies in which magnesium sulfate is used as an adjuvant in anesthesia administration. 4, 5) It has been suggested that magnesium has the potential to treat and prevent pain by acting as an antagonist of N-methyl-D-aspartate (NMDA) receptors. 6) The development of hypomagnesemia has been reported in 60−70% of postoperative patients. 7, 8) Also reduced serum magnesium concentration is related with perioperative morbidity. 9, 10) We performed a study to characterize response in serum magnesium concentration in patients undergoing elective major abdominal surgery under remifentanil-based anesthesia. We also tested the hypothesis that magnesium infusion decreases postoperative pain and opioid requirement in patients undergoing major abdominal surgery under remifentanil-based anesthesia.
MATERIALS AND METHODS
After obtaining approval from the Institutional Review Board and written informed consent, 70 ASA I−II patients undergoing elective major abdominal surgery were enrolled in the study. Patients were excluded if they had major hepatic, renal and cardiovascular disease or asthma, chronic obstructive pulmonary disease, as well as known allergy to magnesium sulfate or other drugs, and treatment with calcium channel blocker, opioids and anticoagulant.
The patients were assigned randomly to one of two groups.
The magnesium group (group M) received 25% magnesium sulfate and the control group (group C) received 0.9% normal saline in a double blind fashion. The solutions were prepared by the coordinator of the study, and the anesthesiologist in Values are mean ± SD or number of patients. *: P ＜ 0.05 compared with group C. PPPD: pylorus preserving pancreaticoduodenectomy. 
RESULTS
The two groups were comparable with respect to age, weight, gender distribution, procedure, duration of anesthesia, administered crystalloid and dysrhythmia. Remifentanil consumption was statistically greater in group C than in group M. The time to first postoperative analgesic requirement was significantly longer in group M than in group C. Patients in group M significantly received less total rocuronium consumption than in group C. Hypotension, bradycardia, and nausea were statistically similar in both groups. Shivering was significantly lower in group M than in group C ( Table 1 ).
The patients in both groups had significantly lower serum albumin, and hematocrit concentrations postoperatively than preoperatively. Whereas serum total magnesium in group C was significantly decreased, total magnesium in group M was significantly increased in the postoperative concentration than on preoperative concentration (Table 2) .
VAS scores for pain were significantly lower in group M than in group C for postoperative 12 hours after surgery (Table 3) . Cumulative analgesic consumption through PCA device was significantly lower in group M than in group C at 6, 12, 24, and 36 hours (Table 4) . Values are median (range). *: P ＜ 0.05 compared with group C. 
DISCUSSION
We confirmed our hypothesis that magnesium infusion decreases postoperative pain and opioid requirement in patients undergoing major abdominal surgery under remifentanil-based anesthesia. Consequently, patients in the control group required analgesics earlier and required greater doses to achieve satisfactory analgesia. Interestingly, this increased morphine consumption.
Hypomagnesemia has been proposed as the most underdiagnosed electrolyte deficiency, and routine monitoring has been recommended for patient populations with or at high risk of developing cardiac dysrhythmias.
11) The development of hypomagnesemia has been reported in postoperative and critically ill patients. 12, 13) The detailed mechanism of postoperative hypomagnesemia, to date, has not been determined.
However, the decrease in total serum magnesium concentrations correlated with the degree of hypoalbuminemia, indicating a reduction in the protein bound fraction of magnesium. Serum total protein and albumin concentrations decreased during surgery: total protein and albumin concentrations decreased significantly in correlation with fluid administration, with an average decrease of almost 40% for albumin. In this study, the volume of administered crystalloid was correlated significantly with the reduction in total magnesium. We determined that serum magnesium levels were lower postoperatively in group C. Although this decrease was significant, we believe that it is not important clinically. Indeed, no clinical symptoms of hypomagnesemia were observed in our patients. However, there is evidence that the response of the NMDA receptors is greatly enhanced by reducing the extracellular magnesium concentration below the physiological level.
14)
It has been shown that magnesium sulfate has analgesic efficacy and reduces the need for postoperative analgesics because it acts as a NMDA antagonist and blocks calcium channels. 4, 5, 15, 16) However some investigators have suggested that magnesium sulfate infusion has no effect on postoperative analgesia, basing their reasoning on the fact that only a small proportion of the i.v administered magnesium sulfate crosses the blood-brain barrier. 17, 18) Clinical reports of reduced postoperative analgesic requirements with i.v infusion of magnesium sulfate, support our finding of potentiated opioid analgesia by magnesium, although this effect has not always been seen clinically.
19)
The mechanism of potentiation seen in some clinical studies is probably a different mechanism than that seen with intrathecal drug administration, because even at large plasma concentrations, only a small amount of the magnesium ion crosses the blood-brain barrier. McCarthy et al. 20) reported that conversely, plasma concentrations, even after continuous intrathecal infusion, are not increased in rats. Therefore, it is likely that magnesium can potentiate opioid analgesic effects by both central and peripheral mechanisms.
Conflicting results have been published concerning the effect of the volatile anesthetics at very low concentrations (i.e., 0.05 −0.1 minimum alveolar concentrations) on pain. some studies have demonstrated an increase in pain threshold 21, 22) However, other studies found no hypoalgesic or hyperalgesic effect of subanesthetic concentrations of inhalation anesthetics. 23, 24) Our data demonstrated a significant reduction in rocuronium consumption during general anesthesia with continuous magnesium sulfate infusion. The effect on rocuronium consumption is not surprising as the effect of magnesium ions at the neuromuscular junction are well known. Not unexpectedly, magnesium was shown to decrease the risk of postoperative shivering. In healthy volunteers, magnesium sulfate (80 mg/kg bolus followed by an infusion at 2 g/hr)
was shown to reduce the shivering threshold. 25) In clinical practice, magnesium's beneficial effect on shivering is of minor importance compared with, for the efficacy that was reported with meperidine or clonidine. 26) In conclusion, Intraoperative magnesium supplementation has favorable effect on neuromuscular blockade, shivering, postoperative pain intensity and analgesic requirement without impairing hemodynamic parameters. Therefore, it may be worthwhile to further study the role of magnesium as supplements to intraoperative anesthetics and postoperative analgesia, since this molecule is inexpensive, relatively harmless, and the biological basis for its potential antinociceptive effect is promising.
